MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 146 filers reported holding MYOKARDIA INC in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,012,000 | +37.2% | 14,761 | -2.7% | 0.01% | +12.5% |
| Q2 2020 | $1,466,000 | +249.0% | 15,177 | +69.4% | 0.01% | +166.7% |
| Q1 2020 | $420,000 | -64.0% | 8,960 | -44.1% | 0.00% | -40.0% |
| Q4 2019 | $1,168,000 | +27.7% | 16,020 | -8.7% | 0.01% | 0.0% |
| Q3 2019 | $915,000 | +7.0% | 17,544 | +2.9% | 0.01% | 0.0% |
| Q2 2019 | $855,000 | -5.4% | 17,055 | -2.0% | 0.01% | 0.0% |
| Q1 2019 | $904,000 | +7.4% | 17,397 | +0.9% | 0.01% | -16.7% |
| Q4 2018 | $842,000 | -37.1% | 17,237 | -16.0% | 0.01% | -33.3% |
| Q3 2018 | $1,338,000 | +30.0% | 20,522 | -0.9% | 0.01% | +28.6% |
| Q2 2018 | $1,029,000 | +10.8% | 20,717 | +8.8% | 0.01% | +16.7% |
| Q1 2018 | $929,000 | -0.4% | 19,033 | -14.1% | 0.01% | 0.0% |
| Q4 2017 | $933,000 | – | 22,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $54,445,000 | 40.54% |
| Copernicus Capital Management, LLC | 42,186 | $5,751,000 | 5.48% |
| Casdin Capital, LLC | 870,000 | $118,607,000 | 5.31% |
| Foresite Capital Management IV, LLC | 126,492 | $17,245,000 | 3.89% |
| Avoro Capital Advisors LLC | 1,885,000 | $256,982,000 | 3.65% |
| RTW INVESTMENTS, LP | 936,931 | $127,732,000 | 3.08% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $8,979,000 | 2.90% |
| Perceptive Advisors | 1,395,017 | $190,183,000 | 2.78% |
| Fernwood Investment Management, LLC | 38,547 | $5,255,000 | 2.48% |
| Grace Capital | 23,400 | $3,190,000 | 2.47% |